Sunesis Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report

Sunesis Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

KeyHighlights

Sunesis Pharmaceuticals, Inc (Sunesis or 'the company') is a biopharmaceutical company that develops and commercializes oncology therapeutics for the treatment of hematologic and solid cancers. The company’s major products include Vosaroxin, TAK-580, SSN-510 and Vecabrutinib. The company has collaboration agreement with Biogen Idec MA, Inc. to discover, develop and commercialize small molecule inhibitors of the human protein Raf kinase and with Takeda Pharmaceutical Company Limited to develop and commercialize preclinical inhibitors of PDK1 and TAK-580. It conducts various clinical trails and analysis for developing products that identifies and implements alternative methods for treating cancer and also obtain licenses for developing various critical products. The company is headquartered in South San Francisco, California, the US.

Scope

– Detailed information on Sunesis Pharmaceuticals, Inc. required for business and competitor intelligence needs

– A study of the major internal and external factors affecting Sunesis Pharmaceuticals, Inc. in the form of a SWOT analysis

– An in-depth view of the business model of Sunesis Pharmaceuticals, Inc. including a breakdown and examination of key business segments

– Intelligence on Sunesis Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

– News about Sunesis Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins

– Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Sunesis Pharmaceuticals, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Sunesis Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Sunesis Pharmaceuticals, Inc.'s business structure, strategy and prospects.

Table of Contents

Table of Contents

Company Snapshot 2

Table of Contents 5

Sunesis Pharmaceuticals, Inc.: Company Overview 9

Sunesis Pharmaceuticals, Inc.: Overview and Key Facts 9

Sunesis Pharmaceuticals, Inc.: Overview 9

Sunesis Pharmaceuticals, Inc.: Key Facts 9

Sunesis Pharmaceuticals, Inc.: Key Employees 11

Sunesis Pharmaceuticals, Inc.: Key Employee Biographies 12

Sunesis Pharmaceuticals, Inc.: Major Products and Services 16

Sunesis Pharmaceuticals, Inc.: Company History 17

Sunesis Pharmaceuticals, Inc.: Management Statement 20

Sunesis Pharmaceuticals, Inc.: Locations and Subsidiaries 25

Sunesis Pharmaceuticals, Inc.: Key Competitors 26

Sunesis Pharmaceuticals, Inc.: Company Analysis 27

Sunesis Pharmaceuticals, Inc.: Business Description 27

Sunesis Pharmaceuticals, Inc.: SWOT Analysis 28

Sunesis Pharmaceuticals, Inc.: SWOT Overview 28

Sunesis Pharmaceuticals, Inc.: Strengths 28

Sunesis Pharmaceuticals, Inc.: Weaknesses 29

Sunesis Pharmaceuticals, Inc.: Opportunities 29

Sunesis Pharmaceuticals, Inc.: Threats 29

Sunesis Pharmaceuticals, Inc.: Corporate Financial Deals Activity 31

Sunesis Pharmaceuticals, Inc.: Financial Deals Overview 31

Sunesis Pharmaceuticals, Inc.: Top Deals 2015 - 2019YTD* 33

Sunesis Pharmaceuticals, Inc.: Advisors 34

Sunesis Pharmaceuticals, Inc.: Top Legal Advisors 34

Sunesis Pharmaceuticals, Inc.: Top Financial Advisors 34

Sunesis Pharmaceuticals, Inc.: Capital Raising 35

Sunesis Pharmaceuticals, Inc.: Recent Developments 36

Sunesis Pharmaceuticals, Inc.: News and Events Summary 36

Sunesis Pharmaceuticals, Inc.: Corporate Governance 39

Sunesis Pharmaceuticals, Inc.: Financial Deals 40

Sunesis Pharmaceuticals, Inc.: Financial Performance 40

Sunesis Pharmaceuticals, Inc.: Regulatory and Legal Events 41

Sunesis Pharmaceuticals, Inc.: Research & Development 42

Sunesis Pharmaceuticals, Inc.: Strategy and Operations 43

Appendix 44

Contact Us 44

Methodology 44

About MarketLine 45

List of Tables

List of Tables

Table 1: Sunesis Pharmaceuticals, Inc.: Key Facts 9

Table 2: Sunesis Pharmaceuticals, Inc.: Key Employees 11

Table 3: Sunesis Pharmaceuticals, Inc.: Company History 17

Table 4: Sunesis Pharmaceuticals, Inc.: Locations and Subsidiaries 25

Table 5: Sunesis Pharmaceuticals, Inc.: Key Competitors 26

Table 6: Sunesis Pharmaceuticals, Inc.: Deal Activity by Deal Type – Volume (TTM*) 31

Table 7: Sunesis Pharmaceuticals, Inc.: Deal Activity by Deal Type – Volume (2015 – YTD*2019) 32

Table 8: Sunesis Pharmaceuticals, Inc.: Top Deals 2015 – 2019YTD* 33

Table 9: Sunesis Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m) 34

Table 10: Sunesis Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m) 34

Table 11: Sunesis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2015 – YTD*2019) 35

Table 12: Sunesis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2015 – YTD*2019) 35

Table 13: Sunesis Pharmaceuticals, Inc.: News and Events Summary 36

Table 14: Sunesis Pharmaceuticals, Inc.: Corporate Governance 39

Table 15: Sunesis Pharmaceuticals, Inc.: Financial Deals 40

Table 16: Sunesis Pharmaceuticals, Inc.: Financial Performance 40

Table 17: Sunesis Pharmaceuticals, Inc.: Regulatory and Legal Events 41

Table 18: Sunesis Pharmaceuticals, Inc.: Research & Development 42

Table 19: Sunesis Pharmaceuticals, Inc.: Strategy and Operations 43

List of Figures

List of Figures

Figure 1: Sunesis Pharmaceuticals, Inc.: Deal Activity by Deal Type – Volume (TTM*) 31

Figure 2: Sunesis Pharmaceuticals, Inc.: Deal Activity by Deal Type – Volume (2015 – YTD*2019) 32

Figure 3: Sunesis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2015 – YTD*2019) 35

Figure 4: Sunesis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2015 – YTD*2019) 35

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports